South San Francisco, CA, United States of America

Vaxart, Inc.

Calculating rank
USPTO Granted Patents = 6



Trademarks = 3

Forward Citations = 5

Loading Chart...
Loading Chart...

8 inventors (with patents filed for the assignee):

goldMedal Sean Tucker (5 out of 55 patents)

silverMedal George Robert Trager (2 out of 7 patents)

bronzeMedal Ciaran Daniel Scallan (2 out of 9 patents)

4.  Leesun Kim (2 out of 2 patents)

5.  Delphine Compere (1 out of 8 patents)

6.  Marta Blumenfeld (1 out of 38 patents)

7.  Jean-Michel Gauthier (1 out of 4 patents)

8.  Richard K Plemper (9 patents)

9.  Sean N Tucker (0 patent)

10.  Elyse Bourque (0 patent)

11.  Eddy Lee (0 patent)

12.  John Vernachio (0 patent)

13.  Richard K Plemper (0 patent)


6 patents:

Company Overview
Vaxart, Inc. is a clinical-stage biotechnology company focused on developing oral recombinant vaccines. The company utilizes its proprietary oral vaccine platform to create vaccines for a variety of infectious diseases. Vaxart's lead vaccine candidates target influenza, norovirus, and respiratory syncytial virus. By delivering vaccines orally, Vaxart aims to improve vaccine efficacy and compliance. Founded in 2004 and headquartered in South San Francisco, Vaxart is committed to revolutionizing the field of vaccine development.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Nov 17 2026

6 Patents

#137 in South San Francisco, CA

#10,611 in California

#45,134 in US

South San Francisco, CA (US)
South San Francisco, CA, United States of America
Forward Citations = 5

8 inventors:

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Vaxart, Inc.. Retrieved from https://idiyas.com/company/vaxart

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…